Correction: The Role of Immune Cell Senescence in Chronic Bone Disorders
Background
Immune cell senescence is a significant factor in the aging process, contributing to chronic inflammation and altered bone metabolism.
Data Highlights
No numerical or trial data is presented in the correction article.
Key Findings
The funding statement was corrected to reflect support from the Hunan Provincial Natural Science Foundation.
Previous funding sources included the Administration of Traditional Chinese Medicine of Jiangxi Province and Jiangxi Provincial Natural Science Foundation.
Immune cell senescence connects aging, inflammation, and bone metabolism disruption.
Clinical Implications
Accurate funding disclosures are vital for maintaining the integrity of research findings. Clinicians should be aware of the evolving understanding of immune mechanisms in chronic bone disorders to inform treatment approaches.
Conclusion
The correction of the funding statement enhances the credibility of the research on immune cell senescence and its role in chronic bone disorders.
In a small open-label randomized trial, 2 platelet-rich plasma injections were associated with greater 6-month improvements in pain and function than corticosteroid injection or oral aceclofenac among patients awaiting knee arthroplasty.
A long-term cohort study found that obesity was not associated with worse patient-reported outcomes or higher reoperation rates following total ankle replacement in optimized surgical candidates.
